Q1 2024 Coloplast A/S Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining the Coloplast interim financial statement for Q1 2023/'24 Conference Call. (Operator Instructions) I would now like to turn the conference over to Kristian Villumsen, President and CEO. Please go ahead.
/-&
Good morning. Thank you, operator, and welcome to our Q1 '23/'24 conference call. I'm Kristian Villumsen, the CEO of Coloplast, and I'm joined by our CFO, Anders Lonning-Skovgaard; and our Investor Relations team. We'll start like we usually do with a short presentation by Anders and myself, and then we'll open up for questions.
Can I ask you all to please turn to Slide #3. We delivered 8% organic growth and a reported EBIT margin before special items of 28%. Return on invested capital after tax and before special items was 15% a level, which reflects the full impact from the Kerecis acquisition in which we expect to be the trough. I'm satisfied with the solid start of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
